{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:07:44Z","timestamp":1780956464316,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijpt.2026.101316","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:54:11Z","timestamp":1776408851000},"page":"101316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Robust Four\u2010Field and Arc LET-Optimized Proton Prostate Cancer Treatment Plans With Urethral Sparing"],"prefix":"10.1016","volume":"20","author":[{"given":"Michael","family":"Vieceli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Saki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardev","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Artz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpt.2026.101316_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijpt.2026.101316_bib2","first-page":"286","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int\u00a0J\u00a0Radiat Oncol\u00a0Biol\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.eururo.2011.08.029","article-title":"Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes","volume":"60","author":"Zelefsky","year":"2011","journal-title":"Eur. Urol"},{"key":"10.1016\/j.ijpt.2026.101316_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/COC.0000000000000285","article-title":"Impact of radiation therapy dose escalation on prostate cancer outcomes and toxicities","volume":"41","author":"Zaorsky","year":"2018","journal-title":"Am J Clin Oncol\u00a0Cancer Clin\u00a0Trials"},{"key":"10.1016\/j.ijpt.2026.101316_bib5","first-page":"787","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J\u00a0Clin\u00a0Oncol"},{"key":"10.1016\/j.ijpt.2026.101316_bib6","first-page":"799","article-title":"Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion","volume":"72","author":"Fonteyne","year":"2008","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol\u00a0Biol\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.prnil.2018.03.005","article-title":"Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review","volume":"6","author":"Feutren","year":"2018","journal-title":"Prostate Int"},{"key":"10.1016\/j.ijpt.2026.101316_bib8","first-page":"1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcima of the prostate. A randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"J\u00a0Am\u00a0Med\u00a0Assoc"},{"key":"10.1016\/j.ijpt.2026.101316_bib9","first-page":"422","article-title":"Five-year biochemical results, toxicity, and patient-reported quality of life after delivery of dose-escalated image guided proton therapy for prostate cancer","volume":"95","author":"Bryant","year":"2016","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol Biol\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16040780","article-title":"Potential therapeutic improvements in prostate cancer treatment using pencil beam scanning proton therapy with LETd optimization and disease-specific RBE models","volume":"16","author":"Vieceli","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijpt.2026.101316_bib11","first-page":"7338","article-title":"The LET trilemma: conflicts between robust target coverage, uniform dose, and dose-averaged LET in carbon therapy","volume":"50","author":"Fredriksson","year":"2023","journal-title":"Med\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib12","first-page":"42","article-title":"Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer","volume":"104","author":"Zelefsky","year":"2019","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol\u00a0Biol\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib13","first-page":"778","article-title":"Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol\u00a0Biol\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib14","first-page":"75","article-title":"Radiation dose to the intraprostatic urethra correlates strongly with urinary toxicity after prostate stereotactic body radiation therapy: a combined analysis of 23 prospective clinical trials","volume":"112","author":"Leeman","year":"2022","journal-title":"Int\u00a0J\u00a0Radiat Oncol\u00a0Biol\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib15","first-page":"92","article-title":"Intraprostatic urethra: the new kid on the block for prostate cancer radiation therapy?","volume":"113","author":"Zilli","year":"2022","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Oncol\u00a0Biol\u00a0Phys"},{"issue":"118","key":"10.1016\/j.ijpt.2026.101316_bib16","first-page":"1","article-title":"Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system","volume":"9","author":"Shimizu","year":"2014","journal-title":"Radiat Oncol."},{"key":"10.1016\/j.ijpt.2026.101316_bib17","first-page":"23","article-title":"A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer","volume":"20","author":"Yoshimura","year":"2021","journal-title":"Phys Imag\u00a0Radiat\u00a0Oncol"},{"issue":"82","key":"10.1016\/j.ijpt.2026.101316_bib18","first-page":"1","article-title":"Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy","volume":"7","author":"Vainshtein","year":"2012","journal-title":"Radiat Oncol."},{"key":"10.1016\/j.ijpt.2026.101316_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02841860410002824","article-title":"The radiobiology of prostate cancer including new aspects of fractionated radiotherapy","volume":"44","author":"Fowler","year":"2005","journal-title":"Acta Oncol\u00a0(Madr))"},{"key":"10.1016\/j.ijpt.2026.101316_bib20","article-title":"Range uncertainties in proton therapy and the role of Monte Carlo simulations","volume":"57","author":"Paganetti","year":"2012","journal-title":"Phys Med\u00a0Biol"},{"key":"10.1016\/j.ijpt.2026.101316_bib21","first-page":"8399","article-title":"A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data","volume":"60","author":"McNamara","year":"2015","journal-title":"Phys\u00a0Med\u00a0Biol"},{"key":"10.1016\/j.ijpt.2026.101316_bib22","first-page":"27","article-title":"The incorporation of the concept of minimum RBE (RBEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments","volume":"83","author":"Carabe-Fernandez","year":"2007","journal-title":"Int J\u00a0Radiat\u00a0Biol"},{"key":"10.1016\/j.ijpt.2026.101316_bib23","first-page":"1013","article-title":"Fractionation and late rectal toxicity","volume":"60","author":"Brenner","year":"2004","journal-title":"Int\u00a0J\u00a0Radiat Oncol\u00a0Biol\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib24","first-page":"3691","article-title":"Investigating the impact of alpha\/beta and LETd on relative biological effectiveness in scanned proton beams: an in vitro study based on human cell lines","volume":"47","author":"Mara","year":"2020","journal-title":"Med\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib25","first-page":"65","article-title":"A simple sequentially rejective multiple test","volume":"6","author":"Holm","year":"1979","journal-title":"Scand\u00a0J\u00a0Stat"},{"key":"10.1016\/j.ijpt.2026.101316_bib26","first-page":"253","article-title":"Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy","volume":"142","author":"Pedersen","year":"2020","journal-title":"Radiother\u00a0Oncol"},{"key":"10.1016\/j.ijpt.2026.101316_bib27","first-page":"223","article-title":"Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and \u03b1\/\u03b2 = 2 Gy overestimates the RBE","volume":"173","author":"Eichkorn","year":"2022","journal-title":"Radiother\u00a0Oncol"},{"key":"10.1016\/j.ijpt.2026.101316_bib28","article-title":"LET-weighted doses effectively reduce biological variability in proton radiotherapy planning","volume":"63","author":"McMahon","year":"2018","journal-title":"Phys\u00a0Med\u00a0Biol"},{"key":"10.1016\/j.ijpt.2026.101316_bib29","first-page":"1","article-title":"Proton radiography and tomography with application to proton therapy","volume":"88","author":"Poludniowski","year":"2015","journal-title":"Br\u00a0J\u00a0Radiol"},{"key":"10.1016\/j.ijpt.2026.101316_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1070\/PU1992v035n04ABEH002227","article-title":"Radiation acoustics","volume":"35","author":"Lyamshev","year":"1992","journal-title":"Sov\u00a0Phys Uspekhi"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101316_bib31","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1118\/1.597429","article-title":"Photoacoustic ultrasound (PAUS)--Reconstruction tomography","volume":"22","author":"Kruger","year":"1995","journal-title":"Med Phys."},{"key":"10.1016\/j.ijpt.2026.101316_bib32","first-page":"937","article-title":"Feasibility of RACT for 3D dose measurement and range verification in a water phantom","volume":"42","author":"Alsanea","year":"2015","journal-title":"Med\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib33","first-page":"2100","article-title":"Development of array-type prompt gamma measurement system for in vivo range verification in proton therapy","volume":"39","author":"Min","year":"2012","journal-title":"Med\u00a0Phys"},{"key":"10.1016\/j.ijpt.2026.101316_bib34","first-page":"2","article-title":"Prompt gamma measurements for locating the dose falloff region in the proton therapy","volume":"89","author":"Min","year":"2006","journal-title":"Appl\u00a0Phys Lett"},{"key":"10.1016\/j.ijpt.2026.101316_bib35","first-page":"1063","article-title":"Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy","volume":"56","author":"Moteabbed","year":"2011","journal-title":"Phys\u00a0Med Biol"},{"key":"10.1016\/j.ijpt.2026.101316_bib36","first-page":"275","article-title":"Is it possible to verify directly a proton-treatment plan using positron emission tomography?","volume":"26","author":"Vynckier","year":"1993","journal-title":"Radiother\u00a0Oncol"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518026000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518026000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:53:56Z","timestamp":1780955636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518026000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"alternative-id":["S2331518026000193"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101316","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robust Four\u2010Field and Arc LET-Optimized Proton Prostate Cancer Treatment Plans With Urethral Sparing","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"101316"}}